Announcements Trials
Browse Landscape

Status

Completed 2Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Carcinoma, Non-Small-Cell Lung 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Tubular Adenocarcinoma 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Infections 1Hemangioma, Cavernous, Central Nervous System 1Hemangioma 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Gallbladder Cancer Unresectable 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Cancer-Related Condition 1Cachexia 1Brenner Tumor 1Biliary Tract Neoplasms 1Arthritis, Rheumatoid 1

Interventions

Fluorouracil 19Oxaliplatin 17Capecitabine 16Leucovorin 14Cisplatin 12Irinotecan 11Gemcitabine 11Drug Therapy 11Bevacizumab 10Radiosurgery 9Cetuximab 9pembrolizumab 8Docetaxel 8Everolimus 7spartalizumab 6Sunitinib 6Radiotherapy 6Paclitaxel 6Neoadjuvant Therapy 6Trastuzumab 5S 1 (combination) 5Nivolumab 5Immunotherapy 5Immune Checkpoint Inhibitors 5Cyclophosphamide 5Chemotherapy, Adjuvant 5Carboplatin 5palbociclib 4manganese chloride 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasm Metastasis × Observation × Clear all
NCT02560311 2015-09-25

Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis

University of Zurich

Unknown
100 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡